July 30 | Standards and precise and infinite care -the sixth session of the Lili Lili China Gastroenterology Tumor Summit Forum is about to start

*For medical professionals for reading reference

The year after five years, as always, speaking academics. On July 30, 2022 (Saturday), the sixth session of the Lili Lili China Gastroenterology Tumor Summit Forum is about to strike. Since the first session of the Summit Forum in 2017, it has been successfully held for five sessions. With high -quality academic content and the style close to clinical practice, it has become an academic ceremony that has attracted much attention in the field of digestive tumors. Here, the medical community invites you to participate in this conference!

The main theme of this year's peak forum is "the forefront of smart gathering, unlimited future", focusing on the four themes of "specifications, precision, infinite, care". Professor Xu Ruihua and Professor Zhang Suzhan, the Second Affiliated Hospital of Zhejiang University Medical College, as the chairman of the conference, gathered well -known experts in the field of digestive tumors in China, and discussed the focus of colorectal cancer in multi -directional and multi -perspectives. Difficulties and hotspots, communication experience, collision thinking, and jointly help the development of Chinese gastrointestinal tumor diagnosis and treatment. At that time, well -known experts in the field of digestive tract gathered offline, the cloud meets, multi -platform broadcasts are broadcast simultaneously, wonderful, not to be missed! Please share the audiovisual academic feast.

In this issue of the medical community, one of the chairman of the conference, Professor Xu Ruihua from Sun Yat -sen University Tumor Prevention and Treatment Center, shared the experience of standardized diagnosis and treatment of colorectal cancer.

Expert Introduction

Xu Ruihua

Ph.D., professor, doctoral supervisor

Chief expert of colorectal cancer internal medicine

Director of Sun Yat -sen University Tumor Prevention and Treatment Center, Director of the Institute, Director of the State Key Laboratory of South China Oncology, Director of the Coordinated Innovation Center of the Provincial Ministry of Ministry of Ministry, and Director of the National New Medicine (Anti -Cancer Drug) Clinical Test Center

Selected into Nanyue Baijie Talent Training Project, National Ten million Talent Project, and National Health Family Planning Outstanding Contribution Middle -aged and Young Experts

Member of the Department of Biology and Medicine, Science and Technology of the Ministry of Education

Chairman of the China Clinical Oncology Society (CSCO)

Vice Chairman of China Anti -Cancer Association

Chairman of the Guangdong Anti -Cancer Association

The first chairman of the Chinese Anti -Cancer Association A targeted treatment committee

The chairman of the Chinese Anti -Cancer Association Chemotherapy Special Committee

Chairman of the Council of the Instal Cancer Professional Committee of the China Clinical Oncology Society

"Cancer Communications" editor -in -chief

National Food and Drug Administration (CFDA) drug review and consulting expert

Professor Xu Ruihua:

With the development of accurate therapy and genetic testing technology, the diagnosis and treatment of colorectal cancer has entered the era of precision treatment guided by molecular typing; standardized treatment is undoubtedly the prerequisite for precision treatment and individual chemical treatment.

For more experts to interview wonderful content, please click to read the original text in the lower left corner to see the details

*This article is only used to provide scientific information to medical people, and does not represent the viewpoint of this platform

- END -